10/21/2010

Aimedics Pty Ltd

Meta analysis presentation – non-invasive detection of nocturnal hypoglycaemia in people with Type 1 diabetes

A review of 10 years of clinical trials on the HypoMon System will be presented by Victor Skladnev CEO AIMEDICS Pty. Ltd (Sydney, Australia) at the Diabetes Technology Meeting in Maryland USA next month. The November 11th presentation is a meta-analysis of clinical results focusing on the accuracy and continual performance improvements in non-invasive hypoglycaemia detection provided by the HypoMon.

For further information, call Sean Gray +61 416 110 935, email sean.gray@aimedics.com or visit www.hypomon.com